Stay updated on FGF401 in HCC and Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the FGF401 in HCC and Solid Tumors Clinical Trial page.

Latest updates to the FGF401 in HCC and Solid Tumors Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has undergone significant changes, including the removal of detailed study objectives and criteria for a clinical trial involving FGF401 in patients with hepatocellular carcinoma, while adding a new version number and the term 'Hepatocellular Carcinoma (HCC)'.SummaryDifference20%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.9%
- Check88 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.9%
Stay in the know with updates to FGF401 in HCC and Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FGF401 in HCC and Solid Tumors Clinical Trial page.